Member access

4-Traders Homepage  >  Shares  >  Mercato Continuo Espanol  >  Grifols SA    GRF   ES0171996012

GRIFOLS SA (GRF)

49
Real-time Quote. Real-time Tradegate - 12/19 08:36:48 am
33.108 EUR   +1.50%
12/04 GRIFOLS SA : ex-dividend day for interim dividend
12/01 GRIFOLS : introduces new 40-g IVIG vial size for GAMUNEX-C
11/19 GRIFOLS : contributes to river restoration projects
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Mercato Continuo Espanol
12/12/2014 12/15/2014 12/16/2014 12/17/2014 12/18/2014 Date
31.255(c) 30.155(c) 32.3(c) 31.955(c) 32.62(c) Last
2 365 515 1 545 510 2 118 573 1 758 337 2 076 565 Volume
+0.56% -3.52% +7.11% -1.07% +2.08% Change
More quotes
Company
Grifols SA is a vertically integrated global producer of plasma derivatives.Its activities include sourcing raw material, manufacturing various plasma derivative products and selling and distributing final products to healthcare providers.The company operates through four segments: Bioessence,... 
Sector
Pharmaceuticals
Calendar
02/26Earnings Release
More about the company
Surperformance© ratings of Grifols SA
Trading Rating : Investor Rating :
More Ratings
Chart GRIFOLS SA
Duration : Period :
Grifols SA Technical Analysis Chart | GRF | ES0171996012 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 3 307 M
EBIT 2014 851 M
Net income 2014 481 M
Debt 2014 3 116 M
Yield 2014 1,62%
Sales 2015 3 540 M
EBIT 2015 927 M
Net income 2015 540 M
Debt 2015 2 932 M
Yield 2015 1,92%
PER 2014 23,05
PER 2015 20,30
EV / Sales 2014 4,14x
EV / Sales 2015 3,82x
Capitalization 10 579 M
More Financials
Latest news on GRIFOLS SA
12/04 GRIFOLS SA : ex-dividend day for interim dividend
12/01 GRIFOLS : introduces new 40-g IVIG vial size for GAMUNEX-C
11/19 ARADIGM : Announces Third Quarter 2014 Financial Results
11/19 GRIFOLS : contributes to river restoration projects
11/12 ARADIGM : Posts 3rd Quarter 2014 Financial Results
11/12 ARADIGM : Releases Third Quarter 2014 Financial Results
11/11 ARADIGM : Announces Third Quarter 2014 Financial Results
11/04 GRIFOLS : rsquo; net profit increases by 26.9% to 339 million euros in the nine ..
More news
Sector news
23m ago ROCHE BEARER SHARE : Ahead of the Bell: ImmunoGen shares tumble
28m ago CELGENE : Receives Positive CHMP Opinion to Extend REVLIMID® (Lenalidomide) for ..
37m ago TEVA PHARMACEUTICAL : Announces FDA Approval of QNASL® (Beclomethasone Dipropion..
More sector news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF